Funded Tech Companies
Targanta Therapeutics
Headquartered in Cambridge, Targanta Therapeutics has funding from OrbiMed, Vengrowth Asset Management and Brookside Capital.
Company Overview
Company Name
Targanta Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
222 Third St. 2300
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
Targanta Therapeutics is a privately held biopharmaceutical company developing and commercializing antibacterial drugs to treat serious infections in the hospital setting. Its pipeline includes an array of antibacterial agents in various stages of development.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/12/2007
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Leuchtenberger
Chief Financial Officer
George Eldridge
Chief Scientific Officer
Thomas Parr
Vice President
Susan Hager
Vice President
Margaret Wasilewski
VP - Finance
Christian Belisle
VP - General Counsel
Daniel Char
VP - Human Resources
Stanley Merrill
VP - Marketing
Gayle Fischer
VP - Operations
Roger Miller
VP - Regulatory Affairs
William Current
VP - Sales
Ron Wickline
Company Investors
- OrbiMed
- Vengrowth Asset Management (Jeffrey Courtney)
- Brookside Capital (Jay Venkatesan)
- Skyline Ventures (Eric Gordon)
- Radius Ventures
- Seaflower Ventures
- Canadian Medical Discoveries Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs